When did OncoSec Medical Incorporated (ONCS) report earnings last quarter?
OncoSec Medical Incorporated (ONCS) last reported earnings on 6/15/2023.

NASDAQ:ONCS • US68234L4059
Past quarterly earnings results for OncoSec Medical Incorporated (ONCS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | -1.34 | - | 75.71% | - | - | |||
| Q1 2023 | -4.50 | -5.00 | 9.96% | 18.18% | - | - | ||
| Q4 2022 | -4.62 | -5.39 | 14.22% | 27.59% | - | - | ||
| Q3 2022 | -3.52 | -4.04 | 12.85% | 42.86% | - | - | ||
| Q2 2022 | -5.50 | -5.95 | 7.51% | 32.43% | - | - | ||
| Q1 2022 | -5.50 | -8.30 | 33.76% | 48.98% | - | - | ||
| Q4 2021 | -6.38 | -6.43 | 0.82% | -16.00% | - | - | ||
| Q3 2021 | -6.16 | -6.90 | 10.73% | 37.78% | - | - | ||
| Q2 2021 | -8.14 | -8.08 | -0.76% | 70.87% | - | - | ||
| Q1 2021 | -10.78 | -8.08 | -33.44% | 46.74% | - | - | ||
| Q4 2020 | -5.50 | -8.47 | 35.07% | - | - | - | ||
| Q3 2020 | -9.90 | -9.87 | -0.27% | - | - | - | ||
| Q2 2020 | -27.94 | -10.88 | -156.72% | - | - | - | ||
| Q1 2020 | -20.24 | -16.04 | -26.15% | - | - | - |
Notes
OncoSec Medical Incorporated (ONCS) last reported earnings on 6/15/2023.
OncoSec Medical Incorporated (ONCS) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, OncoSec Medical Incorporated (ONCS) has beaten EPS estimates in 3 out of 4 releases.